Insufficient scRNA-seq data for expression of WEE2 at single-cell level.
Insufficient scRNA-seq data for expression of WEE2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 96% | 13.85 | 173 / 180 | 0% | 0.01 | 2 / 430 |
kidney | 96% | 19.04 | 85 / 89 | 1% | 0.01 | 5 / 901 |
brain | 94% | 9.19 | 2481 / 2642 | 2% | 0.03 | 15 / 705 |
uterus | 96% | 10.24 | 163 / 170 | 0% | 0 | 0 / 459 |
breast | 92% | 11.68 | 424 / 459 | 1% | 0.02 | 10 / 1118 |
spleen | 93% | 7.81 | 223 / 241 | 0% | 0 | 0 / 0 |
pancreas | 92% | 8.56 | 301 / 328 | 1% | 0.01 | 1 / 178 |
thymus | 92% | 8.72 | 602 / 653 | 0% | 0 | 0 / 605 |
prostate | 89% | 7.38 | 219 / 245 | 0% | 0 | 0 / 502 |
lung | 88% | 7.42 | 507 / 578 | 1% | 0.03 | 16 / 1155 |
adipose | 86% | 6.50 | 1039 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 6.00 | 1148 / 1335 | 0% | 0 | 0 / 0 |
skin | 86% | 8.81 | 1555 / 1809 | 0% | 0 | 0 / 472 |
stomach | 84% | 4.80 | 301 / 359 | 2% | 0.05 | 6 / 286 |
intestine | 83% | 5.49 | 804 / 966 | 0% | 0.02 | 2 / 527 |
adrenal gland | 81% | 4.93 | 208 / 258 | 0% | 0 | 0 / 230 |
muscle | 80% | 5.19 | 645 / 803 | 0% | 0 | 0 / 0 |
esophagus | 78% | 4.49 | 1127 / 1445 | 1% | 0.02 | 2 / 183 |
bladder | 76% | 5.29 | 16 / 21 | 1% | 0.04 | 5 / 504 |
heart | 70% | 3.37 | 602 / 861 | 0% | 0 | 0 / 0 |
liver | 61% | 2.73 | 138 / 226 | 0% | 0 | 0 / 406 |
peripheral blood | 42% | 1.80 | 391 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0006468 | Biological process | protein phosphorylation |
GO_1900194 | Biological process | negative regulation of oocyte maturation |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0007143 | Biological process | female meiotic nuclear division |
GO_0060631 | Biological process | regulation of meiosis I |
GO_0035038 | Biological process | female pronucleus assembly |
GO_0080154 | Biological process | regulation of fertilization |
GO_0005829 | Cellular component | cytosol |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | WEE2 |
Protein name | Wee1-like protein kinase 2 (EC 2.7.10.2) (Wee1-like protein kinase 1B) (Wee1B kinase) |
Synonyms | WEE1B |
Description | FUNCTION: Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits CDK1/CDC2 and acts as a key regulator of meiosis during both prophase I and metaphase II . Required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, by phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity and prevent meiotic reentry. Also required for metaphase II exit during egg activation by phosphorylating CDK1 at 'Tyr-15', to ensure exit from meiosis in oocytes and promote pronuclear formation (By similarity). . |
Accessions | ENST00000397541.6 ENST00000576319.1 P0C1S8 ENST00000493845.1 H7C5P0 ENST00000574659.5 |